PLX

#3751
Protalix BioTherapeutics, Inc. Common Stock
2.1250 USD
+0.24%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
2.1150
2.1400
年范围
2.0300
3.1900
日变化
+0.24%
每月变动
+0.34%
6个月变化
-27.23%
年变化
-27.23%
前一天收盘价
2.1200
开盘价
2.1250
最低价
2.1150
High
2.1400
交易量
264
展开完整图表

Financials

概览 声明 统计
每季度 年度
利润表 资产负债表 现金流
值 202020212022202320242025

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

新闻